Dr. Antonio Osuna Ortega

Dr. Antonio Osuna Ortega is a Spanish biotechnology research entity led by the eponymous Professor at the University of Granada's Institute of Biotechnology. The entity is a leader in the molecular study of parasites, specifically focusing on the development of advanced diagnostics and therapeutic interventions for Chagas disease and Leishmaniasis. Its portfolio includes the development of recombinant proteins and synthetic peptides used in high-precision diagnostic assays and experimental vaccine candidates. The group's research has led to several patents and successful technology transfers to the pharmaceutical industry for the commercialization of parasitic disease management tools. Key technologies include a platform for identifying antigenic determinants and the production of recombinant antigens in eukaryotic systems. Based in Granada, the entity serves as a critical hub for tropical medicine research and biotechnology innovation in Southern Spain.